News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
764,285 Results
Type
Article (57389)
Company Profile (641)
Press Release (706255)
Multimedia
Podcasts (90)
Webinars (14)
Section
Business (216133)
Career Advice (2965)
Deals (38325)
Drug Delivery (123)
Drug Development (86023)
Employer Resources (176)
FDA (17644)
Job Trends (16225)
News (369454)
Policy (36296)
Tag
Academia (2691)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (95)
Alliances (53943)
ALS (106)
Alzheimer's disease (1495)
Antibody-drug conjugate (ADC) (160)
Approvals (17599)
Artificial intelligence (296)
Autoimmune disease (29)
Automation (16)
Bankruptcy (393)
Best Places to Work (12047)
BIOSECURE Act (22)
Biosimilars (118)
Biotechnology (439)
Bladder cancer (87)
Brain cancer (30)
Breast cancer (312)
Cancer (2475)
Cardiovascular disease (210)
Career advice (2494)
Career pathing (34)
CAR-T (181)
Cell therapy (498)
Cervical cancer (21)
Clinical research (69858)
Collaboration (931)
Company closure (2)
Compensation (594)
Complete response letters (30)
COVID-19 (2813)
CRISPR (50)
C-suite (276)
Cystic fibrosis (110)
Data (2393)
Decentralized trials (2)
Denatured (18)
Depression (55)
Diabetes (297)
Diagnostics (6800)
Digital health (19)
Diversity (5)
Diversity, equity & inclusion (42)
Drug discovery (135)
Drug pricing (131)
Drug shortages (31)
Duchenne muscular dystrophy (106)
Earnings (87036)
Editorial (47)
Employer branding (24)
Employer resources (151)
Events (124475)
Executive appointments (787)
FDA (19094)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (827)
Gene editing (124)
Generative AI (27)
Gene therapy (370)
GLP-1 (859)
Government (4484)
Grass and pollen (6)
Guidances (170)
Healthcare (19161)
Huntington's disease (26)
IgA nephropathy (32)
Immunology and inflammation (156)
Indications (30)
Infectious disease (2976)
Inflammatory bowel disease (157)
Inflation Reduction Act (10)
Influenza (57)
Intellectual property (104)
Interviews (572)
IPO (17594)
IRA (48)
Job creations (4656)
Job search strategy (2072)
Kidney cancer (11)
Labor market (43)
Layoffs (560)
Leadership (24)
Legal (9158)
Liver cancer (81)
Lung cancer (347)
Lymphoma (163)
Machine learning (9)
Management (60)
Manufacturing (369)
MASH (86)
Medical device (14317)
Medtech (14322)
Mergers & acquisitions (21316)
Metabolic disorders (807)
Multiple sclerosis (90)
NASH (22)
Neurodegenerative disease (118)
Neuropsychiatric disorders (34)
Neuroscience (2124)
NextGen: Class of 2025 (7032)
Non-profit (4351)
Now hiring (41)
Obesity (436)
Opinion (273)
Ovarian cancer (84)
Pain (104)
Pancreatic cancer (91)
Parkinson's disease (167)
Partnered (22)
Patents (264)
Patient recruitment (120)
Peanut (51)
People (63357)
Pharmaceutical (132)
Pharmacy benefit managers (24)
Phase I (21652)
Phase II (30652)
Phase III (23087)
Pipeline (1487)
Policy (179)
Postmarket research (2869)
Preclinical (9251)
Press Release (69)
Prostate cancer (115)
Psychedelics (38)
Radiopharmaceuticals (266)
Rare diseases (439)
Real estate (6694)
Recruiting (70)
Regulatory (25018)
Reports (44)
Research institute (2481)
Resumes & cover letters (462)
Rett syndrome (6)
RNA editing (6)
RSV (50)
Schizophrenia (84)
Series A (146)
Series B (98)
Service/supplier (26)
Sickle cell disease (58)
Special edition (20)
Spinal muscular atrophy (161)
Sponsored (34)
Startups (4126)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (58)
The Weekly (71)
Vaccines (820)
Venture capitalists (45)
Weight loss (305)
Women's health (35)
Worklife (20)
Date
Today (257)
Last 7 days (1001)
Last 30 days (3590)
Last 365 days (34569)
2025 (13051)
2024 (37401)
2023 (42134)
2022 (53369)
2021 (57972)
2020 (56043)
2019 (48270)
2018 (36698)
2017 (35874)
2016 (36257)
2015 (42331)
2014 (35907)
2013 (30820)
2012 (32653)
2011 (32878)
2010 (31067)
Location
Africa (953)
Alabama (62)
Alaska (7)
Arizona (241)
Arkansas (13)
Asia (45964)
Australia (7604)
California (6795)
Canada (2124)
China (573)
Colorado (291)
Connecticut (310)
Delaware (168)
Europe (103343)
Florida (981)
Georgia (225)
Hawaii (1)
Idaho (63)
Illinois (590)
India (30)
Indiana (343)
Iowa (12)
Japan (180)
Kansas (111)
Kentucky (27)
Louisiana (14)
Maine (71)
Maryland (991)
Massachusetts (5195)
Michigan (248)
Minnesota (431)
Mississippi (2)
Missouri (91)
Montana (31)
Nebraska (25)
Nevada (69)
New Hampshire (69)
New Jersey (1899)
New Mexico (30)
New York (1894)
North Carolina (1150)
North Dakota (8)
Northern California (2947)
Ohio (220)
Oklahoma (11)
Oregon (45)
Pennsylvania (1474)
Puerto Rico (14)
Rhode Island (36)
South America (1391)
South Carolina (28)
South Dakota (1)
Southern California (2511)
Tennessee (108)
Texas (1006)
United States (25665)
Utah (197)
Virginia (170)
Washington D.C. (69)
Washington State (613)
West Virginia (3)
Wisconsin (71)
764,285 Results for "c b s scientific company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Sponsored
Sino Biological’s New Center for Bioprocessing (C4B): US-Based CRO Services
In October 2023,
Sino Biological, Inc.
opened its
Center for Bioprocessing (C4B)
in Houston, Texas. The C4B represents a considerable global expansion of the company’s contract research service capabilities.
September 9, 2024
·
3 min read
Earnings
Takeda Pledges $30B in U.S., Argues Against Trump’s ‘Most Favored Nation’ Proposal
Takeda’s Julie Kim argues that Trump’s idea to match drug prices to that of other countries could cost the industry up to $1 trillion over the next 10 years.
May 8, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Microbix Presenting at Investor Conference in B.C.
February 19, 2025
·
4 min read
Press Releases
Genflow Biosciences PLC Announces Holding(s) in Company
May 12, 2025
·
9 min read
Press Releases
Senti Bio Bolsters Scientific Advisory Board with Appointment of James B. Trager, Ph.D.
April 10, 2025
·
7 min read
I&I
Sanofi Commits up to $1.9B for Dren Bio’s Bispecific Antibody for Autoimmune Disease
The deal is the latest in a series of Sanofi investments in its immunology portfolio. According to Sanfoi, DR-0201 can achieve deep B cell depletion, giving it the potential to reset the immune system.
March 20, 2025
·
2 min read
·
Tristan Manalac
Neuroscience
GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact
GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.
April 7, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference
May 8, 2025
·
1 min read
Press Releases
Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company
April 16, 2025
·
5 min read
Editorial
Biomedical Innovation in Jeopardy as Kennedy Distorts, Denies Scientific Truths
As the Trump administration—including HHS Secretary Robert F. Kennedy Jr.—plays fast and loose with scientific studies and facts, there may be a more sinister force at play: censorship.
May 2, 2025
·
6 min read
·
Heather McKenzie
1 of 76,429
Next
